Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ENZ Stock Forecast 2026-2027
$0.54
Current Price
$16.44M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to ENZ Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
ENZ Price Momentum
0.0%
1 Week Change
0.0%
1 Month Change
-10.0%
1 Year Change
0.0%
Year-to-Date Change
-55.0%
From 52W High of $1.20
+114.2%
From 52W Low of $0.25
📊 TOP ANALYST CALLS
Did ENZ Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Enzo Biochem is one of their latest high-conviction picks.
Latest ENZ Stock Price Targets & Analyst Predictions
ENZ has shown a year-to-date change of 0.0% and a 1-year change of -10.0%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for ENZ. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ENZ Analyst Ratings
0
Buy
0
Hold
0
Sell
ENZ Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $0.54
Latest ENZ Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ENZ.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 4, 2014 | Craig-Hallum | Buy | Initiates | $5.50 | |
| Jul 2, 2013 | Sidoti & Co. | Neutral | Initiates | $N/A |
Enzo Biochem, Inc. (ENZ) Competitors
The following stocks are similar to Enzo Biochem based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Enzo Biochem, Inc. (ENZ) Financial Data
Enzo Biochem, Inc. has a market capitalization of $16.44M with a P/E ratio of -1.1x. The company generates $29.09M in trailing twelve-month revenue with a -73.3% profit margin.
Revenue growth is -14.3% quarter-over-quarter, while maintaining an operating margin of -21.8% and return on equity of -12.9%.
Valuation Metrics
Market Cap
$16.44M
Enterprise Value
$-20,390,102
P/E Ratio
-1.1x
PEG Ratio
-0.8x
Price/Sales
0.6x
Growth & Margins
Revenue Growth (YoY)
-14.3%
Gross Margin
+38.8%
Operating Margin
-21.8%
Net Margin
-73.3%
EPS Growth
-20.2%
Financial Health
Cash/Price Ratio
+142.4%
Current Ratio
3.0x
Debt/Equity
6.7x
ROE
-12.9%
ROA
-7.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Enzo Biochem, Inc. (ENZ) Business Model
About Enzo Biochem, Inc.
What They Do
Develops labeling and detection technologies for life sciences.
Business Model
The company generates revenue by offering a range of proprietary products, including labels, dyes, antibodies, and genomic probes, which are essential for drug discovery and development. It also licenses its technology to various clients, including academic and clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers.
Additional Information
Incorporated in 1976 and headquartered in Farmingdale, New York, Enzo Biochem operates both domestically and internationally, focusing on translational research and drug development across multiple scientific fields like cell biology and genomics.
Company Information
Sector
Healthcare
Industry
Diagnostics & Research
Employees
125
CEO
Ms. Kara Cannon
Country
United States
IPO Year
1980
Website
www.enzo.comEnzo Biochem, Inc. (ENZ) Latest News & Analysis
Latest News
Quick Summary
Enzo Biochem reported improved financial results for Q2 FY2025, with increases in revenue, gross margin, and operating profit/loss compared to the previous quarter.
Why It Matters
Enzo Biochem's sequential improvement in revenue, gross margin, and operating profit indicates financial recovery and potential growth, signaling positive momentum for investors.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules
1 year ago
Quick Summary
Enzo Biochem (NYSE: ENZ) is non-compliant with NYSE regulations due to low market capitalization and stockholder equity. It has 18 months to address market cap issues and 6 months for stock price.
Why It Matters
Enzo Biochem faces potential delisting from the NYSE due to low market capitalization and stock price. This raises concerns over financial stability, affecting investor confidence and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Enzo Biochem reported a fiscal Q1 2025 loss and revenue decline due to challenges in the life sciences tools market.
Why It Matters
Enzo Biochem's quarterly loss and declining revenue indicate market challenges, potentially impacting stock performance and investor confidence in the life sciences sector.
Source: Zacks Investment Research
Market Sentiment:
Negative
Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update
1 year ago
Quick Summary
Enzo Biochem, Inc. (NYSE: ENZ) reported its financial results for the fiscal first quarter ending October 31, 2024, on December 16, 2024.
Why It Matters
Enzo Biochem's quarterly financial results can influence stock performance, affecting investor sentiment, valuation, and potential future earnings projections.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend
1 year ago
Quick Summary
Enzo Biochem, Inc. reported its fiscal Q4 and full-year results for 2024. The company's board declared a cash dividend of $0.10 per share.
Why It Matters
Enzo Biochem's financial results and the declaration of a cash dividend signal potential profitability and shareholder returns, influencing stock performance and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Enzo Biochem reported overall revenue growth across most geographic regions, positively impacting its topline performance.
Why It Matters
Enzo Biochem's revenue growth across most regions indicates strong market demand, potentially leading to improved profitability and investor confidence in the company's future performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About ENZ Stock
What is Enzo Biochem, Inc.'s (ENZ) stock forecast for 2026?
Analyst forecasts for Enzo Biochem, Inc. (ENZ) are not currently available. The stock is trading at $0.54.
Is ENZ stock a good investment in 2026?
Analyst ratings for ENZ are not currently available. The stock is currently trading at $0.54. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ENZ stock?
Price predictions from Wall Street analysts for ENZ are not currently available. The stock is trading at $0.54.
What is Enzo Biochem, Inc.'s business model?
The company generates revenue by offering a range of proprietary products, including labels, dyes, antibodies, and genomic probes, which are essential for drug discovery and development. It also licenses its technology to various clients, including academic and clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers.
What is the highest forecasted price for ENZ Enzo Biochem, Inc.?
Price targets from Wall Street analysts for ENZ are not currently available. The stock is trading at $0.54.
What is the lowest forecasted price for ENZ Enzo Biochem, Inc.?
Price targets from Wall Street analysts for ENZ are not currently available. The stock is trading at $0.54.
What is the overall ENZ consensus from analysts for Enzo Biochem, Inc.?
Analyst ratings for ENZ are not currently available. The stock is trading at $0.54.
How accurate are ENZ stock price projections?
Stock price projections, including those for Enzo Biochem, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 7, 2026 6:06 AM UTC